Cumberland And Gloria Announce Joint R&D Investment

News: US drugmaker Cumberland Pharmaceuticals and Chinese pharmaceutical company Gloria Pharmaceuticals have announced a joint research and development (R&D) investment. Both companies have invested USD1mn in Cumberland Emerging Technologies (CET), which is majority owned by Cumberland and has partnerships with academic research centres to develop promising biopharmaceutical technologies. The investment will be used to speed up the development of CET's pipeline of new product candidates emerging from Vanderbilt University and other regional research centres.

Cumberland And Gloria Announce Joint R&D Investment

News: US drugmaker Cumberland Pharmaceuticals and Chinese pharmaceutical company Gloria Pharmaceuticals have announced a joint research and development (R&D) investment. Both companies have invested USD1mn in Cumberland Emerging Technologies (CET), which is majority owned by Cumberland and has partnerships with academic research centres to develop promising biopharmaceutical technologies. The investment will be used to speed up the development of CET's pipeline of new product candidates emerging from Vanderbilt University and other regional research centres.

×

Enter your details to read the full article

By submitting this form you are acknowledging that you have read and understood our Privacy Policy.

×

REQUEST A DEMO

By submitting this form you are acknowledging that you have read and understood our Privacy Policy.

Thank you for your interest

A member of the team will be in touch shortly to arrange a convenient time for your free demonstration and trial. If your enquiry is urgent, please email our Client Services team here.